Astrocyte release of inflammatory cytokines disrupts the BBB in MS by activating endothelial cells [1, 34], so astrocyte-binding autoantibodies could challenge BBB integrity and affect entire regions of neurons as observed in NMO with autoantibodies against AQP4 [41, 54]. Here, AQP4 is linked to myeloid sarcoma.